Platform Overview
Features
Cardiac AmyloidosisHeart FailureAortic StenosisPulmonary HypertensionStrain
Operations
Operational ImpactIT & ProcurementReimbursementsCore Lab SolutionsEHR Mining
Clinical Evidence
Our StoryCareersMedia Kit
NewsContact Us Login Book a Demo

Automate Your Echo Core Lab

Zero inter-reader variability. Fully automated analysis. Structured data outputs in under two minutes.

Faster enrolment Lower variability risk Predictable timelines

Echocardiography remains one of the most variable imaging modalities in clinical trials

Manual core labs introduce compounding risks that grow with every additional site, patient, and timepoint.

Reader-dependent variability

Measurements shift with every reader, creating inconsistent data across sites and timepoints.

Inconsistent protocol adherence

Manual workflows make it difficult to enforce measurement protocols uniformly across labs.

20-30+ minutes per study

Throughput depends on specialist availability, not trial demand.

Bottlenecks as trial size grows

Every additional site multiplies operational complexity.

Scarce expert readers

Qualified echo readers are a finite, expensive resource. Demand outpaces supply.

From Manual Core Lab to Fully Automated

See how Us2.ai compares to current approaches.

Traditional

Manual Core Lab

  • Manual frame selection & measurement
  • Up to 21% inter-reader variability
  • 250+ clicks & 30 min per study
  • Specialist-dependent throughput
  • Ad-hoc QA, no audit trail
  • Manual eligibility review post-upload
Emerging

AI-Assisted Analysis

  • AI suggests measurements
  • Reduced variability
  • Still requires click-by-click approval
  • Partial automation only
  • No integrated workflow management
  • No eligibility or outlier automation
Us2.ai

Automated Core Lab

  • Zero-click AI measurement generation
  • Eliminates inter-reader variability
  • Full report in under 2 minutes
  • Scales without specialist headcount
  • Structured 4-stage QA with audit log
  • Real-time eligibility & outlier detection

From DICOM Upload to Clean Data, Automatically

Us2.ai slots into your existing core lab infrastructure and processes studies end-to-end.

DICOM
Site Upload

DICOMs uploaded via link or batch integration

Eligibility Check

Protocol criteria verified instantly at upload

Us2.ai Analysis

Full echo report in under 2 minutes, zero clicks

QA
Core Lab QA

4-stage review with full audit trail

REPORT
Data Delivered

Clean CSV and statistical outputs to sponsor or CRO

Input

Any DICOM-compliant echo device. Single or bulk upload. Retrospective and prospective designs.

Processing

Cloud or on-premise. Automated view classification, measurement, outlier detection, and eligibility screening.

Output

Structured CSV and report data. Audit-logged, anonymised, and ready for biostatistics and regulatory submission.

Choose Your Level of Automation

Add AI to your current lab Automate workflow management Full end-to-end core lab
Option 1

The AI Engine

Us2.ai Software & License

On-premise or Cloud

Add AI-powered echo analysis to your existing workflow. Protocol-matched structured outputs, no infrastructure overhaul.

  • Automated 2D, Doppler & Strain
  • Protocol-matched CSV extraction
  • On-premise or AWS cloud
  • Study review & editing interface
  • Guideline-compliant, zero clicks
Option 3

Next Gen Core Lab

Full end-to-end automation suite

Full Automation Suite

Complete Cloud Lab with end-to-end trial management and real-time prospective upload for Phase I–IV studies.

  • All Option 2 capabilities
  • Prospective upload at point-of-echo
  • Configurable workflow protocol
  • Longitudinal analysis & tracking
  • Bulk retrospective data upload
  • Real-time trial monitoring
  • Anonymisation & audit traceability

Used in the HELIOS-B Cardiovascular Clinical Trial

Us2.ai software supported echocardiographic analysis in HELIOS-B, a large Phase III multicenter trial evaluating vutrisiran in patients with ATTR cardiomyopathy.

JACC Journal of the American College of Cardiology • Volume 86, No. 6

Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With Cardiomyopathy

HELIOS-B Study Phase III • Multicenter • ATTR Cardiomyopathy
"Echocardiographic measurements were performed using commercially available software (US2ai) in accordance with American Society of Echocardiography guidelines." Study Procedures and Echocardiographic Methods, HELIOS-B
Software Used For Echo measurement analysis
Guideline Standard ASE-compliant measurements
Review Process All AI outputs reviewed by expert readers
Trial Design Large multicenter, serial echocardiography

Ready to Get Started?

Join the clinical teams already running faster, cleaner, and more consistent trials with Us2.ai.

Talk to Our Core Lab Team

Tell us about your trial and we'll walk you through the right Us2.ai solution. We typically respond within one business day.

  • AI Engine software licensing
  • Cloud Lab implementation & configuration
  • Trial protocol alignment
  • Site training & onboarding support
Request Received!

Thank you for your interest. Our core lab team will review your details and get back to you within one business day.